# Ondansetron

NDC: 72336-073
Generic name: Ondansetron
Labeler / Manufacturer: Lifsa Drugs LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20061226

FDA application: ANDA077406

## Active ingredients

- ONDANSETRON: 16 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72336-073"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72336-073
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c66d63cf-a0e5-4cb5-bdf8-9d1115cba23e